Granted share options generally expire at the earlier of termination of employment or ten years from the date of grant. Share options generally vest over four years of the employment commencement date or with 25% vesting on the twelve-month anniversary of the employment commencement date, and the remaining on a pro-rata basis each quarter over the next three years. Any options, which are forfeited or not exercised before expiration, become available for future grants.

The following table summarizes the Company’s share option activity during the six months ended June 30, 2026:


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (000’s)




















Balance, December 31, 2025	3,197,713	$	6.7	5.7	$	45,031
Granted	—	—
Exercised	(44,593)	7.4
Forfeited	(31,042)	23.5
Balance, June 30, 2026	3,122,078	$	6.6	5.2	$	36,349
Vested and exercisable, June 30, 2026	2,595,276	$	4.9	4.6	$	34,620

The aggregate intrinsic value of options exercised, and fair value of share options vested for the six months ended June 30, 2026 was $0.4 million and $1.4 million, respectively.

As of June 30, 2026, unrecognized compensation expense related to unvested share options was approximately $3.6 million, which is expected to be recognized over a remaining weighted-average vesting period of 1.3 years.

RSUs for new employees generally vest over two years of the employment commencement date with 50% vesting on the twelve-month anniversary of the employment commencement date, and the remaining on a pro-rata basis each quarter over the remaining twelve months. RSUs for existing employees are granted periodically and generally vest quarterly over 2 years. Unvested RSUs are forfeited at termination of employment. Any RSUs that are forfeited become available for future grants.

The following table summarizes the Company’s RSU activity during the six months ended June 30, 2026:


	Number of RSUs	Weighted Average Grant Date Fair Value Per Share












Unvested at December 31, 2025	2,150,173	$	14.5
Granted	2,421,411	12.1
Vested	(1,188,186)	13.2
Forfeited	(278,782)	13.2
Unvested at June 30, 2026	3,104,616	$	13.3

As of June 30, 2026, unrecognized compensation expense related to RSUs was approximately $37.7 million, which is expected to be recognized over a remaining weighted-average period of 0.9 years.

The following table summarizes the Company’s options to restricted shares activity during the six months ended June 30, 2026:


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (000’s)
















Balance, December 31, 2025	19,884,985	$	19.3	5.2	$	30,967
Granted	—	—
Exercised	—	—
Forfeited	(1,691)	40.1
Balance, June 30, 2026	19,883,294	$	19.3	4.7	$	—
Vested and exercisable, June 30, 2026	16,577,977	$	19.3	4.7	$	—

As of June 30, 2026, unrecognized compensation expense related to options to restricted shares was approximately $4.0 million, which is expected to be recognized over a remaining weighted-average period of 0.8 years.

The Employee Stock Purchase Plan (“ESPP”) allows eligible employees to purchase our Class A Ordinary Shares at a discounted price, normally through payroll deductions, subject to the terms of the ESPP and applicable law. During the six months ended June 30, 2026, 66,814 shares were issued under the ESPP. Compensation expense related to the ESPP was $0.2 million and $0.3 million for the three and six months ended June 30, 2026, respectively.

The following table presents the components and classification of share-based compensation for the three and six months ended June 30, 2026 and 2025 (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Technology, data and product development	$	1,061	$	1,326	$	2,255	$	2,423
Sales and marketing	1,584		8,731		3,115		13,511
General and administrative	5,924		8,171		10,395		15,466
Total	$	8,569	$	18,228	$	15,765	$	31,400